Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386968440> ?p ?o ?g. }
- W4386968440 endingPage "1046" @default.
- W4386968440 startingPage "1033" @default.
- W4386968440 abstract "Cancer-related anorexia is a common complication and frequently occurs in cancer patients treated with vascular endothelial growth factor receptor-tyrosine kinase inhibitors (VEGFR-TKIs). Anorexia contributes to malnutrition, body weight loss, and cachexia in affected patients. Furthermore, patients who experience anorexia have worse outcomes than those who maintain their appetite, highlighting the importance of managing anorexia and related symptoms. However, as the causes of anorexia are both diverse and interconnected, there have been challenges in evaluating and implementing effective interventions. In this review, we described the contributing factors to cancer-related anorexia and reviewed recent literature for the frequency of anorexia symptoms in patients treated with VEGFR-TKIs. Additionally, we evaluated the evidence for current interventions and the potential benefits of multimodal and multidisciplinary approaches to care. The frequency of anorexia symptoms in patients who received VEGFR-TKIs ranged from 14%-58% for all-grade anorexia and 0%-6% for grade 3 or 4 anorexia. While many of the interventions for cancer-related anorexia have minimal benefit or adverse events, recent advances in our understanding of cancer-related anorexia suggest that multimodal therapy with multidisciplinary care is a promising avenue of investigation. Several studies currently underway are anticipated to further assess the effectiveness of multimodal approaches." @default.
- W4386968440 created "2023-09-23" @default.
- W4386968440 creator A5018910129 @default.
- W4386968440 creator A5033954465 @default.
- W4386968440 creator A5064560515 @default.
- W4386968440 creator A5072348132 @default.
- W4386968440 creator A5076020482 @default.
- W4386968440 creator A5077086654 @default.
- W4386968440 date "2023-09-01" @default.
- W4386968440 modified "2023-10-17" @default.
- W4386968440 title "The Incidence and Management of Cancer-Related Anorexia During Treatment with Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitors" @default.
- W4386968440 cites W1600754102 @default.
- W4386968440 cites W1655617308 @default.
- W4386968440 cites W1665341330 @default.
- W4386968440 cites W1964995585 @default.
- W4386968440 cites W1965087543 @default.
- W4386968440 cites W1966920013 @default.
- W4386968440 cites W1967792499 @default.
- W4386968440 cites W1971837077 @default.
- W4386968440 cites W1999966467 @default.
- W4386968440 cites W2003064100 @default.
- W4386968440 cites W2006202082 @default.
- W4386968440 cites W2013369101 @default.
- W4386968440 cites W2027206507 @default.
- W4386968440 cites W2075441909 @default.
- W4386968440 cites W2081561618 @default.
- W4386968440 cites W2082736377 @default.
- W4386968440 cites W2087076688 @default.
- W4386968440 cites W2090302698 @default.
- W4386968440 cites W2096805784 @default.
- W4386968440 cites W2099088585 @default.
- W4386968440 cites W2103689170 @default.
- W4386968440 cites W2108177971 @default.
- W4386968440 cites W2110236737 @default.
- W4386968440 cites W2116749750 @default.
- W4386968440 cites W2116922255 @default.
- W4386968440 cites W2116949558 @default.
- W4386968440 cites W2116976533 @default.
- W4386968440 cites W2117895335 @default.
- W4386968440 cites W2122956665 @default.
- W4386968440 cites W2132833374 @default.
- W4386968440 cites W2134131507 @default.
- W4386968440 cites W2135022015 @default.
- W4386968440 cites W2139511378 @default.
- W4386968440 cites W2147834058 @default.
- W4386968440 cites W2158474413 @default.
- W4386968440 cites W2168076926 @default.
- W4386968440 cites W2203411824 @default.
- W4386968440 cites W2237254160 @default.
- W4386968440 cites W2278001291 @default.
- W4386968440 cites W2289778032 @default.
- W4386968440 cites W235910007 @default.
- W4386968440 cites W2385650477 @default.
- W4386968440 cites W2505149831 @default.
- W4386968440 cites W2560499218 @default.
- W4386968440 cites W2569392536 @default.
- W4386968440 cites W2596750082 @default.
- W4386968440 cites W2611376562 @default.
- W4386968440 cites W2621762107 @default.
- W4386968440 cites W2623370342 @default.
- W4386968440 cites W2626721982 @default.
- W4386968440 cites W2706197370 @default.
- W4386968440 cites W2735430493 @default.
- W4386968440 cites W2740159257 @default.
- W4386968440 cites W2743558319 @default.
- W4386968440 cites W2745540258 @default.
- W4386968440 cites W2765228582 @default.
- W4386968440 cites W2774323119 @default.
- W4386968440 cites W2786125682 @default.
- W4386968440 cites W2787358630 @default.
- W4386968440 cites W2788888327 @default.
- W4386968440 cites W2792937256 @default.
- W4386968440 cites W2802374582 @default.
- W4386968440 cites W2803344884 @default.
- W4386968440 cites W2803473262 @default.
- W4386968440 cites W2809889937 @default.
- W4386968440 cites W2884174104 @default.
- W4386968440 cites W2887469236 @default.
- W4386968440 cites W2897833471 @default.
- W4386968440 cites W2901644252 @default.
- W4386968440 cites W2926851859 @default.
- W4386968440 cites W2936300667 @default.
- W4386968440 cites W2947108008 @default.
- W4386968440 cites W2968736548 @default.
- W4386968440 cites W2977494173 @default.
- W4386968440 cites W2995898751 @default.
- W4386968440 cites W3009100563 @default.
- W4386968440 cites W3011469361 @default.
- W4386968440 cites W3013845573 @default.
- W4386968440 cites W3016801235 @default.
- W4386968440 cites W3028453792 @default.
- W4386968440 cites W3031873331 @default.
- W4386968440 cites W3034797015 @default.
- W4386968440 cites W3041709199 @default.
- W4386968440 cites W3045453384 @default.
- W4386968440 cites W3045507545 @default.
- W4386968440 cites W3087542764 @default.
- W4386968440 cites W3091870917 @default.